A detailed history of Pro Share Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 1,252,429 shares of ABBV stock, worth $225 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
1,252,429
Previous 1,309,684 4.37%
Holding current value
$225 Million
Previous $225 Million 10.1%
% of portfolio
0.62%
Previous 0.61%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $9.38 Million - $11.4 Million
-57,255 Reduced 4.37%
1,252,429 $247 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $4.04 Million - $4.72 Million
26,088 Added 2.03%
1,309,684 $225 Million
Q1 2024

May 08, 2024

SELL
$159.82 - $182.1 $8.12 Million - $9.26 Million
-50,834 Reduced 3.81%
1,283,596 $234 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $28 Million - $31.5 Million
-203,257 Reduced 13.22%
1,334,430 $207 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $25.7 Million - $29.8 Million
192,632 Added 14.32%
1,537,687 $229 Million
Q2 2023

Aug 10, 2023

SELL
$132.51 - $164.9 $13 Million - $16.2 Million
-98,385 Reduced 6.82%
1,345,055 $181 Million
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $15.7 Million - $18 Million
108,304 Added 8.11%
1,443,440 $230 Million
Q4 2022

Feb 02, 2023

BUY
$138.31 - $165.87 $1.34 Million - $1.61 Million
9,677 Added 0.73%
1,335,136 $216 Million
Q3 2022

Nov 04, 2022

SELL
$134.21 - $153.93 $3.63 Million - $4.17 Million
-27,073 Reduced 2.0%
1,325,459 $178 Million
Q2 2022

Aug 01, 2022

SELL
$137.62 - $174.96 $28.6 Million - $36.3 Million
-207,457 Reduced 13.3%
1,352,532 $207 Million
Q1 2022

May 10, 2022

SELL
$131.98 - $163.75 $25.3 Million - $31.4 Million
-191,538 Reduced 10.94%
1,559,989 $253 Million
Q4 2021

Feb 08, 2022

BUY
$107.43 - $135.93 $25.6 Million - $32.4 Million
238,062 Added 15.73%
1,751,527 $237 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $1.41 Million - $1.6 Million
13,266 Added 0.88%
1,513,465 $163 Million
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $23.2 Million - $25.9 Million
220,847 Added 17.26%
1,500,199 $169 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $18.6 Million - $20.5 Million
-182,306 Reduced 12.47%
1,279,352 $138 Million
Q4 2020

Feb 09, 2021

BUY
$80.49 - $108.67 $21.8 Million - $29.4 Million
270,318 Added 22.69%
1,461,658 $157 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $1.11 Million - $1.3 Million
12,882 Added 1.09%
1,191,340 $104 Million
Q2 2020

Aug 03, 2020

SELL
$73.37 - $98.18 $15.9 Million - $21.3 Million
-216,761 Reduced 15.54%
1,178,458 $116 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $18.5 Million - $28 Million
-286,839 Reduced 17.05%
1,395,219 $106 Million
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $1.09 Million - $1.37 Million
15,161 Added 0.91%
1,682,058 $149 Million
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $22.2 Million - $26.6 Million
351,803 Added 26.75%
1,666,897 $126 Million
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $13.1 Million - $16.8 Million
199,885 Added 17.92%
1,315,094 $95.6 Million
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $2.21 Million - $2.6 Million
-28,621 Reduced 2.5%
1,115,209 $89.9 Million
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $10.2 Million - $12.6 Million
130,976 Added 12.93%
1,143,830 $105 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $4.08 Million - $4.53 Million
45,870 Added 4.74%
1,012,854 $95.8 Million
Q2 2018

Aug 13, 2018

BUY
$89.78 - $106.23 $534,191 - $632,068
5,950 Added 0.62%
966,984 $89.6 Million
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $5.16 Million - $6.9 Million
-56,042 Reduced 5.51%
961,034 $91 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $1.71 Million - $1.88 Million
-19,147 Reduced 1.85%
1,017,076 $98.4 Million
Q3 2017

Nov 13, 2017

SELL
$69.85 - $89.22 $6.04 Million - $7.71 Million
-86,463 Reduced 7.7%
1,036,223 $92.1 Million
Q2 2017

Aug 11, 2017

BUY
N/A
1,122,686
1,122,686 $81.4 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.